Segmentation of modern dosage forms at the pharmaceutical market of Ukraine
DOI:
https://doi.org/10.24959/nphj.22.94Keywords:
segment; capsules; pharmaceutical market of Ukraine; content analysisAbstract
In the current conditions of the pharmaceutical industry development the segmentation of available dosage forms among 13898 medicines registered on the territory of Ukraine allows to optimize the pharmaceutical provision of the population.
Aim. To comprehensively analyze medicines registered in Ukraine.
Materials and methods. The study material was data of the State Register of Medicines of Ukraine in 2022. The research methods used were frequency and content analysis.
Results and discussion. As a result of the content analysis, it has been found that the pharmaceutical market of Ukraine is represented by 13898 items of medicines; among them 10965 are ready-made medicinal products (78.89 %) and 2146 are substances (15.44 %), where the largest share is made up of finished dosage forms, namely
solid dosage forms: tablets (49.96 %), solutions (17.17 %), capsules (10.37 %) and powders (10.01 %) with a preference for foreign production of 66.35 %. Medicines in the form of capsules and their varieties with the advantage of foreign production of 76.01 % of trade names are also determined.
Conclusions. As a result of the content analysis, the range of dosage forms registered on the territory of Ukraine amounting to 13898 trade names has been determined. Solid dosage forms (tablets, capsules) account for 6617 trade names and occupy 60.35 % of the pharmaceutical market of Ukraine. When analyzing manufacturers of modern dosage forms it has been found that the ratio of capsules of foreign and domestic production is 2:1, where Indian dosage
forms make up 18.54 %.
References
Кулицький С. Фармацевтична галузь і фармацевтичний ринок в Україні: стан і проблеми розвитку. Україна: події, факти, коментарі. 2019. № 6. С. 41–53.
Про затвердження Положення про Державний реєстр лікарських засобів : Постанова Кабінету Міністрів України № 411 від 31 березня 2004 р. URL: https://zakon.rada.gov.ua/laws/show/411-2004- %D0 %BF#Text.
Ковінько О. М., Cтахова А. І., Вовк А. П. Фармацевтичний ринок України як рушійний важіль розвитку економіки. Науковий вісник Ужгородського національного університету. Серія: Міжнародні економічні відносини та світове господарство. 2017. № 11. С. 56–59.
Притульська Н. В., Мотузка Ю. М., Кошельник А. В. Фармацевтичний ринок України: тенденції розвитку в умовах пандемії Сovid-19. Товари ринки. 2022. № 41 (1). С. 19–29.
Державний реєстр лікарських засобів : інформаційний фонд. URL: http://www.drlz.com.ua/ibp/ddsite.nsf/all/shlist?opendocument.
Державна фармакопея України / ДП “Науково-експертний фармакопейний центр”. 1-е вид., доп. 1. Харків : РІРЕГ, 2004. 292 с.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
